Peptídeos e Proteínas
Os peptídeos são cadeias curtas de aminoácidos ligadas por ligações peptídicas, enquanto as proteínas são cadeias mais longas e complexas de aminoácidos que podem adotar estruturas tridimensionais funcionais. Ambos os tipos de compostos são essenciais para diversas funções biológicas, como a catálise de reações (enzimas), a defesa imunológica (anticorpos) e a sinalização celular. As proteínas possuem uma estrutura hierárquica que inclui a sequência de aminoácidos, bem como as estruturas secundária, terciária e quaternária. Os peptídeos são utilizados em terapias farmacológicas e cosméticas devido às suas propriedades biológicas específicas, como no tratamento de doenças metabólicas ou na melhoria da regeneração celular. As proteínas, por sua vez, possuem aplicações em biotecnologia, nutrição e medicina regenerativa.
Na CymitQuimica, oferecemos peptídeos e proteínas de alta pureza para pesquisa em biotecnologia e aplicações terapêuticas.
Foram encontrados 3118 produtos de "Peptídeos e Proteínas"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
N-Nitroso-D,L-proline-d3
CAS:Produto Controlado<p>Applications A labelled nitrosoamino acid with oncogenic activity.<br>References Nagasawa, H.T., et al.: J. Med. Chem., 16, 583 (1973)<br></p>Fórmula:C52H3H5N2O3Cor e Forma:Off-WhitePeso molecular:147.147(AlphaS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
CAS:Produto Controlado<p>Impurity Lopinavir EP Impurity R<br>Applications (αS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide (Lopinavir EP Impurity R) is an impurity of Lopinavir (L469480), a selective HIV protease inhibitor.<br>References Chitturi, S.R., et al.: J. Pharma. Biomed. Anal., 48, 1430 (2008); Devi, A.S.L., et al.: Magnet. Reson. Chem., 45, 424 (2007);<br></p>Fórmula:C47H58N4O7Cor e Forma:NeatPeso molecular:791.05-Oxo-L-proline-d5
CAS:Produto Controlado<p>Applications 5-Oxo-L-proline-d5 is a labelled cyclized derivative of L-Glutamic Acid (G596960). The pyroglutamate core has potential application for synthesis of novel anti-bacterials.<br>References Mischo A. et al.: ChemBioChem., 13, 1421 (2012); Angelov P. et al.: Org. Biomol. Chem.: 10, 3472 (2012);<br></p>Fórmula:C52H5H2NO3Cor e Forma:White To Off-WhitePeso molecular:134.14Deschloro-4’-chloro Clomiphene Hydrochloride
CAS:Produto Controlado<p>Applications An impurity of Clomiphene (C587025).<br></p>Fórmula:C26H29Cl2NOCor e Forma:NeatPeso molecular:442.42Lopinavir Metabolite M-3/M-4
CAS:Produto Controlado<p>Applications A major metabolite of Lopinavir (L469480) . It is a COVID19-related research product.<br>References Molla, A., et al.: J. Virology, 250, 255 (1998), Sham, H., et al.: Antimicrob. Agents Chemother., 42, 3218 (1998), Kumar, G., et al.: Drug Metab. Dispos., 27, 86 (1999),<br></p>Fórmula:C37H48N4O6Cor e Forma:NeatPeso molecular:644.80Daptomycin Impurity B1-I
<p>Applications Daptomycin Impurity B1-1 is an impurity of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial.<br>References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),<br></p>Fórmula:C44H66N10O15•(C2HF3O2)Cor e Forma:Off White SolidPeso molecular:975.0511402(alphaR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetic Acid Salt
CAS:Produto Controlado<p>Applications Bortezomib (B675700) intermediate. A boronic acid dipeptide derivative as proteasome inhibitors.<br>References Kisselev, A., et al.: Chem. Biol., 8, 739 (2001), Kisselev, A., et al.: J. Biol. Chem., 278, 35869 (2003), Verdoes, M., et al.: Chem. Biol., 13, 1217 (2006),<br></p>Fórmula:C15H28BNO2·C2HF3O2Cor e Forma:NeatPeso molecular:379.22(S)-N-[1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2yl]pyrazine-2-carboxamide
Produto ControladoFórmula:C19H22N4O4Cor e Forma:NeatPeso molecular:370.4(2S)-1-Nitrosopyrrolidine-2-carboxamide
CAS:Produto ControladoFórmula:C5H9N3O2Cor e Forma:NeatPeso molecular:143.14Boceprevir-d9
CAS:Produto Controlado<p>Applications A labelled NS3 serine protease inhibitor of hepatitis C virus. It is a COVID19-related research product.<br>References Malcolm, B., et al.: Antimicrob. Agents Chemother., 50, 1013 (2006); Cubero, M., et al.: Virology, 370, 237 (2008); Venkatraman, S., et al.: J. Med. Chem., 49, 6074 (2006);<br></p>Fórmula:C272H9H36N5O5Cor e Forma:NeatPeso molecular:528.73Lisinopril (8R,S)-Diketopiperazine (Mixture of Diastereomers)Mps1-IN-1 dihydrochloride
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications Lisinopril (L468985) impurity.<br>References Drummer, O., et al.: Arzneim.-Forsch. Drug Res., 38, 647 (1988), Simpson, K., et al.: Drugs, 59, 1149 (2000),<br></p>Fórmula:C21H29N3O4Cor e Forma:NeatPeso molecular:387.47(S)-Hydroxy Des(boric Acid) Bortezomib
CAS:Produto Controlado<p>Impurity Bortezomib USP Impurity J<br>Applications (S)-Hydroxy Des(boric Acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl, C. et al.: Chem. and Eng. News, 87, 41 (2009)<br></p>Fórmula:C19H24N4O3Cor e Forma:NeatPeso molecular:356.42Lysipressin Acetic Acid Salt
CAS:<p>Applications Lysipressin Acetic Acid Salt, is an analog of Vasopressin (A769550), a powerful vasopressor used to modulate blood pressure. An endogenous antidiuretic hormone in most mammalian species. It is released into the blood from nerve terminals in the posterior pituitary and median eminence. It is a neurotransmitter in the central nervous system and also implicated in a variety of physiological processes such as regulating water balance by antidiuretic action.<br>References Yamashita, K. et al.: Mol. Phylo., 67, 520 (2013); Hua F. et al.: J. Emerg. Med., 44, 434 (2013); Perucca, J. et al.: J. AM. Soc. Nephrol., 19, 1721 (2008); Toba, K. et al.: Prog. Brain Res., 119, 337 (1998); Berrada, K. et al.: J. Biol. Chem., 275, 27229 (2000);<br></p>Fórmula:C46H65N13O12S2·xC2H4O2Cor e Forma:White SolidPeso molecular:1056.23 + (60.05)xTeriparatide-d10
CAS:Produto ControladoFórmula:C181D10H281N55O51S2Cor e Forma:NeatPeso molecular:4127.72(S,S)-Hydroperoxy Des(boric Acid) Bortezomib
CAS:Produto Controlado<p>Impurity Bortezomib USP Impurity L<br>Stability Unstable in Methanol<br>Applications (R)-Hydroperoxy Des(boric Acid) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);<br></p>Fórmula:C19H24N4O4Cor e Forma:White To Off-WhitePeso molecular:372.42N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib
CAS:Produto Controlado<p>Applications N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);<br></p>Fórmula:C19H22N4O3Cor e Forma:White To Off-WhitePeso molecular:354.403(S)-Hydroperoxy Des(boric Acid) Bortezomib
CAS:Produto Controlado<p>Applications (S,S)-Hydroperoxy Des(boric Acid) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);<br></p>Fórmula:C19H24N4O4Cor e Forma:NeatPeso molecular:372.422-((4S,7S,10S,13S,15R)-10-Benzyl-15-hydroxy-7,13-diisobutyl-15-methyl-1-morpholino-2,5,8,11,14,18-hexaoxo-4-phenethyl-17-oxa-3,6,9,12-tetraazanonadecan-19-yl)-2-hydroxysuccinic Acid
<p>Applications 2-((4S,7S,10S,13S,15R)-10-Benzyl-15-hydroxy-7,13-diisobutyl-15-methyl-1-morpholino-2,5,8,11,14,18-hexaoxo-4-phenethyl-17-oxa-3,6,9,12-tetraazanonadecan-19-yl)-2-hydroxysuccinic Acid is an impurity of Carfilzomib (C183460), which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.<br>References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);<br></p>Fórmula:C46H65N5O14Cor e Forma:White To Off-WhitePeso molecular:912.033(alphaS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride
CAS:Produto Controlado<p>Applications (αS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride is a Bortezomib (B675700) intermediate which is used in the evaluation of bone-targeted proteasome inhibitors for myeloma.<br>References Agyin, J.K., et al.: Bioorg. Med. Chem. Lett., 23, 6455 (2013); Traenckner, E., et al.: EMBO. J., 13, 5433 (1994)<br></p>Fórmula:C24H37BN2O3·ClHCor e Forma:NeatPeso molecular:448.8341(D-His2)-Leuprolide Trifluoroacetic Acid Salt
CAS:Produto Controlado<p>Impurity Leuprolide Acetate EP Impurity B TFA salt<br>Applications Synthetic nonapeptide agonist analog of LH-RH. Antineoplastic (hormonal).<br>References Vilchez-Martinez, J.A., et al.: Biochem. Biophys. Res. Commun., 59, 1226 (1974), Sennello, L.T., et al.: J. Pharm. Sci., et al.: 75, 158 (1986), Wheeler, J.M., et al.: Am.J. Obstet. Gynecol., 167, 1367 (1992), Eri, L.M., et al.: J. Urol., 150, 359 (1993),<br></p>Fórmula:C59H84N16O12·x(C2HF3O2)Cor e Forma:NeatPeso molecular:1209.398Voclosporin M1 (IM1-Diol-1) metabolite
Fórmula:C63H113N11O14Pureza:>85%Cor e Forma:NeatPeso molecular:1248.66Bortezomib impurity 76
CAS:<p>Bortezomib impurity 76 is an analytical reference material that is used in the development and production of pharmaceuticals. It is a high purity, HPLC standard for use as an impurity in the manufacture of bortezomib API. This material is a metabolite of bortezomib and it has been shown to be pharmacologically active. Bortezomib impurity 76 can also be used as an HPLC standard for drug product analysis.</p>Fórmula:C21H44BNO2Si2Pureza:Min. 95%Cor e Forma:PowderPeso molecular:409.56 g/mol(S)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
CAS:<p>(S)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid is a drug product of the drug development industry. It is a metabolite of 3-(1,2,4-triazol-1-ylmethyl)thiazolidine-4-carboxylic acid and has been used as an analytical standard for HPLC methods. The compound has been shown to be naturally occurring in humans. (S)-3-(1,2,4-Triazol-1ylmethyl)thiazolidine 4 carboxylic acid is also used as the impurity standard for the API 3-(1,2,4 triazol 1ylmethyl)thiazolidine 4 carboxylic acid.</p>Fórmula:C9H12N2O4SPureza:Min. 95%Peso molecular:244.27 g/mol[9-Glycine]desmopressin
<p>9-Glycine Desmopressin is a drug product that has been custom synthesized for use in research and development. This compound is an impurity standard that is used to identify the 9-glycine desmopressin impurities in the HPLC method. It is also used as a synthesis intermediate for the manufacture of the API. The CAS number for this compound is [CAS NO.]. This compound was manufactured using synthetic methods and has demonstrated high purity.</p>Pureza:Min. 95%(5aR,10aR)-Tetrahydro-3H,5H,8H,10H-bisthiazolo[3,4-a:3',4'-d]pyrazine-5,10-dione
CAS:<p>(5aR,10aR)-Tetrahydro-3H,5H,8H,10H-bisthiazolo[3,4-a:3',4'-d]pyrazine-5,10-dione is a drug product that is an impurity standard for the API (Active Pharmaceutical Ingredient) 5α-tetrahydrospiro[benzofuran-1(3H),2'(3'H)]pyrido-[2,1'-cyclohexan]-6β,7β-(1'H)-dione. It is a metabolite of this API and can be used as a research and development analytical standard for HPLC. The CAS number for this compound is 72744-67-3. This substance has been found in natural products such as the seeds of Sesamum indicum L., Cucurbita maxima Duchesne var.</p>Fórmula:C8H10N2O42S2Pureza:Min. 95%Peso molecular:870.29 g/molLevothyroxine EP impurity B
CAS:<p>Please enquire for more information about Levothyroxine EP impurity B including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Fórmula:C15H11ClI3NO4Pureza:Min. 95%Peso molecular:685.42 g/molN-4,5[Acetylamino)methyl]desmopressin
<p>N-4,5[Acetylamino)methyl]desmopressin is a synthetic drug product that is used as an analytical standard for the identification and quantitation of desmopressin in pharmaceutical preparations. It is also used as an impurity standard for HPLC analysis. This product has been synthesized using a custom synthesis process, and has been shown to be suitable for use in drug development and research and development. N-4,5[Acetylamino)methyl]desmopressin is also available as a high purity HPLC standard that meets pharmacopoeia requirements.</p>Pureza:Min. 95%Levothyroxine lactose adduct
<p>Levothyroxine is a drug product that is used for the treatment of hypothyroidism. It is an analog of thyroxine, which is synthesized in the thyroid gland. Levothyroxine has been chemically synthesized and contains a lactose adduct as an impurity standard. This drug product can be used to research metabolic pathways and metabolism studies with rats. Levothyroxine lactose adducts are used in natural products research and development, such as niche specialty drugs, due to their high purity standards. The CAS number for Levothyroxine lactose adduct is 266-072-3.</p>Fórmula:C27H31I4NO14Pureza:85%MinPeso molecular:1,101.15 g/molLisinopril diketopipirazine
CAS:<p>Lisinopril diketopipirazine is an analytical drug product. The CAS number for this product is 219677-82-4. This product requires a custom synthesis and impurity standard. It is synthesized from lisinopril hydrochloride and diketopiperazine hydrochloride. Lisinopril diketopipirazine is a high purity, pharmacopeia grade drug with a natural amino acid. This product has been used in research and development, niche markets, and drug development.</p>Fórmula:C21H29N3O4Pureza:90%MinCor e Forma:White To Off-White SolidPeso molecular:387.47 g/mol[4-L-Glutamic Acid]-desmopressin
<p>4-L-Glutamic Acid]-desmopressin is an analytical standard that is used to calibrate HPLC systems. This product is a high purity, synthetic, and drug development API impurity that can be used as a drug product or impurity standard. It is also available as an HPLC standard, niche, and custom synthesis. 4-L-Glutamic Acid]-desmopressin has been shown to have pharmacopoeia and CAS No.</p>Pureza:Min. 95%[5-L-Aspartic Acid]-desmopressin
<p>Desmopressin is a synthetic drug that is used to treat diabetes insipidus and bleeding in patients who are on anticoagulants. It is also used as a diagnostic agent to distinguish between central and nephrogenic diabetes insipidus. Desmopressin is a peptide hormone with amino acid sequence L-Asp-D-Phe-L-Arg-L-Phe. It is synthesized by the combination of two amino acids, L-Aspartic Acid and L-Phenylalanine, which are then linked together through an amide bond. The synthesis of desmopressin occurs in two steps: first, the coupling of amino acid L-Aspartic Acid with the peptide linkage (N-[3-(2'-aminoethyl) carbonyl]glycine) to form the intermediate N-[3-(2'-Aminoethyl) carbonyl]-L-Aspartic Acid; second</p>Pureza:Min. 95%(R)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
CAS:<p>(R)-3-((R)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid is a research and development, impurity standard, custom synthesis, drug product, synthetic, high purity, pharmacopoeia, drug development and analytical reagent. CAS No. 162148-17-6</p>Fórmula:C9H12N2O4SPureza:Min. 95%Peso molecular:244.27 g/molN1.9,N1.9-Dimethyldesmopressin
<p>N1.9,N1.9-Dimethyldesmopressin is a synthetic analog of the natural hormone vasopressin. It is used as a drug product in research and development to study drug metabolism, but it has not been approved for use as a drug product by any regulatory agency. Impurities are determined by the USP or EP pharmacopoeia and are present at less than 1% or 2% respectively. The compound is synthesized through high purity chemical synthesis methods with purity greater than 99%.</p>Pureza:Min. 95%(S)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid
CAS:<p>(S)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid is a synthetic compound that is used as an impurity standard for HPLC. It is also used in drug development and research and development of pharmaceuticals. This product was made through custom synthesis and is not natural.</p>Fórmula:C9H12N2O4SPureza:Min. 95%Peso molecular:244.27 g/molL-803087
CAS:<p>L-803087: potent sst4 receptor agonist, 0.7 nM Ki, 280x selectivity, boosts AMPA responses & seizures in mice.</p>Fórmula:C25H29F2N5O3Pureza:97.58%Cor e Forma:SolidPeso molecular:485.53Felypressin acetate
CAS:<p>Felypressin acetate (PLV-2) is an agonist of vasopressin 1 and acts on all arginine vasopressin receptors 1AS.</p>Fórmula:C48H69N13O13S2Pureza:97.06%Cor e Forma:SolidPeso molecular:1100.27Cetrorelix Acetate
CAS:<p>Cetrorelix Acetate is gonadotropin-releasing hormone (GnRH) receptor antagonist with an IC50 of 1.21 nM.</p>Fórmula:C70H92ClN17O14·xC2H4O2Pureza:97.96%Cor e Forma:SolidPeso molecular:1491.11(1S,2S)-Bortezomib
CAS:<p>(1S,2S)-Bortezomib (Bortezomib) is an enantiomer of Bortezomib.</p>Fórmula:C19H25BN4O4Pureza:99.6%Cor e Forma:SolidPeso molecular:384.24D-Ile-23-semaglutide trifluoroacetate
<p>D-Ile(23)-Semaglutide trifluoroacetate is a semaglutide impurity. The amino acid at position 23 has been replaced by the D-form of the amino acid D-isoleucine (D-Ile). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.</p>Pureza:Min. 95%(5aS,10aS)-Tetrahydrodipyrrolo[1,2-a:1',2'-d]pyrazine-3,5,8,10(2H,5aH)-tetraone
CAS:<p>The objective of this project is to design a microcontroller-based system that can monitor and diagnose the level of damage in a composite material. The system will consist of an array of sensors, actuators, and microcontrollers that are connected by a wireless network. The sensors will measure the levels of damage at each point within the composite material. The actuators will provide feedback to the sensors, adjusting their frequency and amplitude based on the level of damage detected. Microcontrollers will be responsible for analyzing data from the sensors and diagnosing any faults in the system. A miniaturized dry skin patch could be used as an alternative to traditional wet skin tests for monitoring skin health.</p>Fórmula:C10H10N2O4Pureza:Min. 95%Peso molecular:222.2 g/molMEDICA16
CAS:<p>MEDICA16: GPR40 agonist, GPR120 partial agonist, ATP-citrate lyase inhibitor, lowers TG, boosts insulin sensitivity in muscle.</p>Fórmula:C20H38O4Pureza:99.62% - 99.87%Cor e Forma:White SolidPeso molecular:342.51AZD-1656
CAS:<p>AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2</p>Fórmula:C24H26N6O5Pureza:97.07% - 99.37%Cor e Forma:SolidPeso molecular:478.5Duostatin 5
CAS:<p>Duostatin 5 (Duo-5) is a sea hare toxin analog commonly used in the synthesis of ADC compounds.</p>Fórmula:C40H69N9O6Pureza:96.98%Cor e Forma:SolidPeso molecular:772.03(Iso)-MS4322
CAS:<p>(Iso)-MS4322 ((Iso)-YS43-22) is a protein arginine methyltransferase 5 (PRMT5 ) degrader with potential anticancer activity.</p>Fórmula:C55H76N10O12SPureza:99.05% - 99.79%Cor e Forma:SolidPeso molecular:1101.32STAT3 degrader-2
CAS:<p>STAT3 Degrader-2 is a PROTAC-based compound that effectively reduces the total STAT3 protein levels, and is utilized in the research of cancer and various</p>Fórmula:C59H62N9O13PPureza:98%Cor e Forma:SolidPeso molecular:1136.15XY028-140
CAS:<p>XY028-140 is a selective CDK4/6 inhibitor and degrader, acting via PROTAC with ligands for Cereblon and CDK in cancer cells.</p>Fórmula:C39H40N10O7Pureza:98.59%Cor e Forma:SolidPeso molecular:760.8[Trp(O)25]-Semaglutide
<p>Semaglutide impurity.</p>Fórmula:C187H291N45O60Peso molecular:4,129.64 g/molC004019
CAS:<p>C004019 is a small molecule PROTAC capable of targeting tau for selective protein degradation from the cell, while recruiting tau and E3 ligase (Vhl) for</p>Fórmula:C49H70N12O9S2Pureza:99.89%Cor e Forma:SoildPeso molecular:1035.29Pidotimod diketopiperazine-6-propanoic acid
CAS:<p>Pidotimod is an impurity in the drug product, which is a synthetic diketopiperazine-6-propanoic acid. Pidotimod is an impurity standard that is used in the development of drugs and as a pharmacopoeia. It has been shown to be metabolized by human liver microsomes and human erythrocytes.</p>Fórmula:C9H12N2O4SPureza:Min. 95%Peso molecular:244.27 g/molReldesemtiv
CAS:<p>Reldesemtiv (CK-2127107) boosts exercise capacity, targeting fast muscle troponin, EC50 3.4 μM.</p>Fórmula:C19H18F2N6OPureza:97.27%Cor e Forma:SolidPeso molecular:384.38LGD-6972
CAS:<p>LGD-6972 is an antagonist of glucagon receptor.</p>Fórmula:C43H46N2O5SPureza:98.8% - 99.62%Cor e Forma:SolidPeso molecular:702.9AMG 837 calcium hydrate
CAS:<p>AMG 837 calcium hydrate is a potent GPR40 agonist with an EC50 of 13 nM.</p>Fórmula:C52H44CaF6O8Pureza:98.07%Cor e Forma:SolidPeso molecular:950.97Pateamine A
CAS:<p>Pateamine A: marine-sourced macrolide from Mycale hentscheli; anticancer, antiviral, and translation inhibitor.</p>Fórmula:C31H45N3O4SCor e Forma:SolidPeso molecular:555.77Marizomib
CAS:<p>Marizomib is a novel irreversible brain-permeable proteasome inhibitor that inhibits CT-L, CT-T-laspase-like, and trypsin-like 20S proteasomes.Cost-effective and quality-assured.</p>Fórmula:C15H20ClNO4Pureza:98.03% - 99.41%Cor e Forma:SolidPeso molecular:313.78FK-565
CAS:<p>FK-565 is a ligand of nucleotide-binding oligomerization domain-1 (NOD1) that induces a mouse model of arteritis.</p>Fórmula:C22H38N4O9Cor e Forma:SolidPeso molecular:502.559c-Kit-IN-7
CAS:<p>c-Kit-IN-7 (compound 104) serves as an effective inhibitor of c-Kit, exhibiting an IC50 of 10 nM or less. It plays a crucial role in cancer research.</p>Fórmula:C27H32FN7O3Cor e Forma:SolidPeso molecular:521.59L-796778 acetate
CAS:<p>L-796778 acetate is a selective sst3 receptor agonist. In CHO-K1 cells expressing hsst3 receptors, it acts as a partial agonist that inhibits Forskolin-induced cAMP production, with an IC50 value of 18 nM. Additionally, L-796778 acetate exhibits anticonvulsant properties.</p>Fórmula:C31H44N6O9Cor e Forma:SolidPeso molecular:644.716(2S,4S)-Sacubitril
CAS:<p>(2S,4S)-Sacubitril (Sacubitril Impurity C) is a stereoisomer derived from Sacubitril which is a potent NEP inhibitor.</p>Fórmula:C24H29NO5Pureza:98%Cor e Forma:SolidPeso molecular:411.49Tabimorelin hemifumarate
CAS:<p>orally active ghrelin receptor (GHS-R1a) agonist</p>Fórmula:C32H40N403C4H404Pureza:98%Cor e Forma:SolidPeso molecular:586.72SSTR5 antagonist 6
CAS:<p>SSTR5 antagonist 6, an orally active antagonist specific to the somatostatin receptor subtype 5 (SSTR5), exhibits an IC50 value of 24 nM. This compound is utilized in researching type 2 diabetes [1].</p>Fórmula:C22H28ClN3O4Cor e Forma:SolidPeso molecular:433.93PIN1 ligand-2
CAS:<p>PIN1ligand-2 (Intermediate M6) is a ligand designed for PROTAC target proteins (Ligands for Target Protein for s). It can be utilized in the synthesis of PROTACT(Rac)-P1D-34.</p>Fórmula:C15H25ClN2O6SCor e Forma:SolidPeso molecular:396.887(S)-dHTC1
CAS:<p>(S)-dHTC1 is a molecular glue degrader specifically targeting the transcriptional coactivator ENL. It exhibits high affinity binding to E3 ligase only upon formation of the ENL:(S)-dHTC1 complex, with an IC50 of 93 nM. In MV4;11 cells, (S)-dHTC1 degrades ENL with a DC50 of 26 nM. This compound can be utilized for acute myeloid leukemia research.</p>Fórmula:C33H40N8O6SCor e Forma:SolidPeso molecular:676.786Isocyclosporin A
CAS:Lactams, nesoiFórmula:C62H111N11O12Cor e Forma:White Off-White PowderPeso molecular:1201.84137Glucagon (HUMAN)
CAS:<p>Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoi</p>Fórmula:C153H225N43O49SCor e Forma:White PowderPeso molecular:3480.6157[L-Leu]6-Leuprolide (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-L-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:<p>Lactams, nesoi</p>Fórmula:C59H84N16O12Cor e Forma:Off-White PowderPeso molecular:1208.64546[Pro(Ac)]1-Leuprolide (5-Oxo-N-acetyl-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:Lactams, nesoiFórmula:C61H86N16O13Cor e Forma:Off-White PowderPeso molecular:1250.65603[O1(Ac)]8-Octreotide (D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(2R,3R)-1-acetoxy-3-hydroxybutan-2-yl]-L-cysteinamide cyclic (2-->7)-disulfide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C51H68N10O11S2Cor e Forma:Off-White PowderPeso molecular:1060.45105[Asp]5-Oxytocin (L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-aspartyl-L-cysteinyl-L-prolyl-L-leucyl-glycinamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C43H65N11O13S2Cor e Forma:Off-White PowderPeso molecular:1007.42047Insulin Human (COLD SHIPMENT REQUIRED) (DISCONTINUED)
CAS:Insulin and its saltsFórmula:C257H383N65O77S6Cor e Forma:White CrystalsPeso molecular:5803.63765[Cys(Ac)]1-Oxytocin (N-Acetyl-L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1-->6)-disulfide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C45H68N12O13S2Cor e Forma:Off-White PowderPeso molecular:1048.44702Cyclosporin H
CAS:<p>Lactams, nesoi</p>Fórmula:C62H111N11O12Cor e Forma:White Off-White SolidPeso molecular:1201.84137[MetO8,18]-Teriparatide
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C181H291N55O53S2Cor e Forma:Off-White SolidPeso molecular:4147.12077[Lys(Ac)]5-Octreotide (D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-N6-acetyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2-->7)-disulfide)
CAS:Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoiFórmula:C51H68N10O11S2Cor e Forma:Off-White PowderPeso molecular:1060.45105[D-His]-Leuprolide (5-Oxo-L-prolyl-D-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:Lactams, nesoiFórmula:C59H84N16O12Cor e Forma:Off-White PowderPeso molecular:1208.64546[D-Ser]-Leuprolide (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-D-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:<p>Lactams, nesoi</p>Fórmula:C59H84N16O12Cor e Forma:Off-White PowderPeso molecular:1208.64546Octreotide Acetate
CAS:<p>Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoi</p>Fórmula:C49H66N10O10S2·xC2H4O2Cor e Forma:White PowderPeso molecular:1018.44048[Ser(Ac)]4-Leuprolide (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-N-acetyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:Lactams, nesoiFórmula:C61H86N16O13Cor e Forma:Off-White PowderPeso molecular:1250.65603D-[Asp]5-Oxytocin (L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-D-aspartyl-L-cysteinyl-L-prolyl-L-leucyl-glycinamide)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Fórmula:C43H65N11O13S2Cor e Forma:Off-White PowderPeso molecular:1007.42047[MetO8]-Teriparatide
Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C181H291N55O52S2Cor e Forma:Off-White PowderPeso molecular:4131.12586[MetO18]-Teriparatide
Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C181H291N55O52S2Cor e Forma:Off-White PowderPeso molecular:4131.12586[Phe(Ac)]1-Octreotide (N-Acetyl-D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2-->7)-disulfide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C51H68N10O11S2Cor e Forma:Off-White PowderPeso molecular:1060.45105Ref: 4Z-L-868
Produto descontinuadoRef: 4Z-H-042003
Produto descontinuadoRef: 4Z-M-198004
Produto descontinuadoRef: 4Z-PS-189078
Produto descontinuadoRef: 4Z-PD-122026
Produto descontinuadoRef: 4Z-M-198002
Produto descontinuadoRef: 4Z-PD-122038
Produto descontinuadoRef: 4Z-PG-194001
Produto descontinuadoRef: 4Z-M-4731
Produto descontinuadoRef: 4Z-PC-5444
Produto descontinuadoRef: 4Z-S-082113
Produto descontinuadoGlatiramer-d7
CAS:Fórmula:C9H4NO3D7·C6H14N2O2·C5H9NO4·C3H7NO2·C2H4OPeso molecular:188.24 146.19 147.13 89.09 60.05Ref: 4Z-G-202
Produto descontinuadoRef: 4Z-S-082106
Produto descontinuadoRef: 4Z-PV-095013
Produto descontinuadoRef: 4Z-S-082111
Produto descontinuadoRef: 4Z-A-7587
Produto descontinuadoRef: 4Z-M-198001
Produto descontinuadoRef: 4Z-H-042002
Produto descontinuado
![(AlphaS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD476505.webp&w=3840&q=75)
![(S)-N-[1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2yl]pyrazine-2-carboxamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FH805105.webp&w=3840&q=75)
![[9-Glycine]desmopressin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIG173262.webp&w=3840&q=75)
![(5aR,10aR)-Tetrahydro-3H,5H,8H,10H-bisthiazolo[3,4-a:3',4'-d]pyrazine-5,10-dione](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIT145578.webp&w=3840&q=75)
![N-4,5[Acetylamino)methyl]desmopressin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIA173214.webp&w=3840&q=75)
![[4-L-Glutamic Acid]-desmopressin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIG173261.webp&w=3840&q=75)
![[5-L-Aspartic Acid]-desmopressin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIA173260.webp&w=3840&q=75)
![(5aS,10aS)-Tetrahydrodipyrrolo[1,2-a:1',2'-d]pyrazine-3,5,8,10(2H,5aH)-tetraone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIT145577.webp&w=3840&q=75)
![[Trp(O)25]-Semaglutide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIS27853.webp&w=3840&q=75)
